Dr. Kerry Deutsch leads the specialty genomics bioinformatics team at Labcorp Drug Development. The team supports data analysis and pipeline development for both the production and research and development arms of the specialty genomics lab, working on a wide variety of assays from qPCR- and array-based platforms to a full spectrum of next-generation sequencing assays including whole-genome sequencing, whole-exome sequencing and targeted panels; whole, targeted and single-cell RNA sequencing; and ctDNA sequencing. She works closely with sponsors to deliver custom analysis solutions in support of their individual research aims.
Kerry received her BA in physics from Johns Hopkins University and her PhD in geophysics from the University of Washington. Prior to joining Labcorp, she worked at a nonprofit biomedical research institute dedicated to a cross-disciplinary approach to investigating complex biological questions.